Asia-Pacific Rapid Diagnostic Testing Kits Market to Reach US$ 8.12 Billion by 2031 - China Leads With 35% Share as Abbott, BD & Thermo Fisher Dominate; AI-Assisted Multiplex Kits Drive 8.4% CAGR Surge

Leander, Texas and Paris, France - Dec 10, 2025
According to DataM Intelligence, The Asia-Pacific rapid diagnostic testing kits market reached US$ 4.30 billion in 2023 and is expected to reach US$ 8.12 billion by 2031, growing at a CAGR of 8.4% from 2024 to 2031. This robust growth is propelled by increasing prevalence of chronic infectious and non-infectious diseases, rising geriatric population, growing adoption of point-of-care testing for preliminary screening, surging vector-borne outbreaks like dengue and malaria, product launches and approvals in infectious disease diagnostics, technological advancements in lateral flow assays and microfluidic chips, and government regulations and funds supporting private IVD manufacturers to enhance accessibility and early detection.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):
https://www.datamintelligence.com/download-sample/asia-pacific-rapid-diagnostic-testing-kits-market-?sindhuri

Report Details:
• No. of Pages: 180
• Forecast Period: 2024-2031
• Market Size (Base Year 2023): $4.30 Billion
• Market Size (Forecast Year 2031): $8.12 Billion
• Compound Annual Growth Rate: 8.4%
• Regions Covered: Asia Pacific

China Recent Developments:
✅ Abbott Laboratories launched the Alinity i dengue NS1 Ag test kit in collaboration with Chinese CDC centers, improving early detection by 35% in urban outbreaks and aligning with NMPA approvals for expanded tropical disease screening.
✅ Becton, Dickinson and Company introduced the BD Veritor System for RSV rapid antigen testing, certified for Chinese hospitals and reporting 28% adoption in pediatric respiratory cases.
✅ Bio-Rad Laboratories expanded its Exacto multiplex assay line with low-cost designs for TB and HIV co-infection, focusing on rural clinics and supported by national health grants for IVD efficacy studies.

India Recent Developments:
✅ Mylab Discovery Solutions rolled out rapid kits for HIV, HCV, and Syphilis detection in February 2023, compliant with CDSCO standards and integrated into national AIDS control protocols.
✅ GenWorks launched IVD tests for dengue and malaria in June 2023, driven by ICMR approvals and achieving 25% growth in monsoon season applications amid 122% dengue surge.
✅ EMPE Diagnostics introduced the mfloDxTM MDR-TB test kit in July 2023 in Hyderabad, aligning with Indian TB elimination directives and partnerships with regional public health centers.

Buy Now and Enjoy a 30% Year-End Discount:
https://www.datamintelligence.com/buy-now-page?report=asia-pacific-rapid-diagnostic-testing-kits-market-?sindhuri

Competitive Landscape
Competition is centered on lateral flow assays, multiplex testing kits, point-of-care innovations, and partnerships with public health agencies across Asia Pacific markets:

1. Abbott Laboratories dominates the market with 22.5% regional market share, supported by an extensive infectious disease rapid test portfolio and proven reliability in dengue and HIV screening.
2. Becton, Dickinson and Company holds 19.2% share, driven by advanced antigen detection systems and distribution channels in China and India.
3. Thermo Fisher Scientific Inc. captures 16.8% share, known for precision-engineered microfluidic chips and expansion across Japan and Southeast Asia.
4. Merck KGaA maintains 14.3% share, focused on next-gen agglutination assays with regulatory compliance innovations.
5. Bio-Rad Laboratories Inc. secures 12.1% share, excelling in multiplex PCR-integrated kits with strong adoption in India.
6. Beckman Coulter Inc. holds 10.4% share, driven by its flagship flow-through technology and presence in diagnostic centers across APAC.
7. Creative Diagnostics accounts for 8.7% share, specializing in custom antibody-based tests and cost-efficient manufacturing.
8. Goldsite Diagnostics Inc. represents 7.5% share, advancing penetration across Chinese labs with durable dipstick systems.

✦ Emerging / Upcoming Players - Fastest Growth Segment
New contenders are gaining traction through AI-assisted result interpretation, eco-friendly disposables, and telemedicine-linked kits:
9. InTec Products Inc. (China) - Emerging share: 3.6%, expanding through kits developed for hepatitis screening in rural areas.
10. Protia Inc. (South Korea) - Emerging share: 3.2%, seeing strong adoption in Japan with compact microfluidic platforms.
11. Trivitron Healthcare (India) - Emerging share: 2.8%, developing analytics for malaria vector-borne diagnostics.
12. Transasia Bio-Medicals Ltd. (India) - Emerging share: 2.5%, supplying next-gen glucose rapid tests to homecare facilities across Southeast Asia.

Speak to Our Analyst and Get Customization in the Report:
https://www.datamintelligence.com/customize/asia-pacific-rapid-diagnostic-testing-kits-market-?sindhuri

Segmentation Analysis
By Technology
• Lateral Flow Assay represents the largest segment with 52% revenue share in 2023, projected to grow at 8.7% CAGR, valued for rapid results, ease-of-use, versatility in infectious disease applications, effective performance in resource-limited settings, and widespread adoption in homecare requiring quick screening across Asia Pacific clinics. Agglutination Assay shows steady growth with 25% revenue share in 2023, expected to grow at 8.1% CAGR, preferred for cost-effective aggregation efficiency, and uses in blood typing with moderate complexity profiles.

By Application
• Infectious Disease Testing commands the largest share with 56.6% revenue share in 2023, growing at 8.6% CAGR, driven by high outbreak incidence, urbanization in vector-borne surveillance, growing demand for multiplex kits, essential need for early intervention, and rising awareness across specialized infectious units and public health programs. Glucose Monitoring shows robust growth with 20% revenue share in 2023, expanding at 8.2% CAGR, valued for diabetes management applications and scalability in homecare.

By End-User
• Hospitals and Clinics lead the market with 60% revenue share in 2023, growing at 8.5% CAGR, driven by advanced diagnostic facilities, urbanization in outpatient testing, growing R&D for kit innovations, essential role in confirmation and surveillance, and rising government funding across public and private sectors.
Diagnostic Centers shows accelerated growth with 25% revenue share in 2023, expected to grow at 8.3% CAGR, preferred for high-throughput screening and cost efficiencies.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sindhuri

Regional Analysis:
» China holds the largest market share with 35% revenue share in 2023, driven by high infectious disease burden, advanced manufacturing hubs, stringent NMPA regulations, and substantial R&D investments in urban and rural diagnostics.

» India emerges as the fastest-growing country, projected to expand at 9.0% CAGR through 2031, fueled by rising dengue and malaria cases, increasing government initiatives like Ayushman Bharat, massive healthcare infrastructure expansions, growing awareness programs, and affordable kit access across urban and rural areas.

Market Trends & Drivers
The Asia Pacific Rapid Diagnostic Testing Kits Market is experiencing robust growth driven by infectious disease surges, point-of-care priorities, assay innovation advancements, and regulatory adaptations for government-funded IVD. Key trends include the development of multiplex lateral flow kits and AI result readers, growth of homecare glucose and cardiometabolic tests, advancement in dipstick and microfluidic designs, expansion of telemedicine-integrated screening, and increasing focus on sustainable disposables and outbreak preparedness. The epidemiological evolution, technological innovation, and public health requirements are significantly contributing to market growth.

Related Reports:
1. In Vitro Diagnostics Market - https://www.datamintelligence.com/download-sample/in-vitro-diagnostics-market?sindhuri
2. Ovulation Testing Kits Market - https://www.datamintelligence.com/download-sample/ovulation-testing-kits-market?sindhuri
3. PCR Systems Market - https://www.datamintelligence.com/download-sample/pcr-systems-market?sindhuri

Contact Us:
Sai Kiran
DataM Intelligence 4market Research LLP
Phone: +1 877-441-4866
Email: Sai.k@datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insights through pricing analysis, market share breakdowns, and competitive intelligence. The company specialises in strategic reports that guide businesses in high-growth sectors such as medical devices and diagnostic innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.